Menu
Recruiting NCT06198010

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors

No phase Interventional Hematopoietic and Lymphoid System Neoplasm Malignant Solid Neoplasm Hematopoietic and Lymphatic System Neoplasm

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Best Practice, Educational Intervention, Questionnaire Administration, Electronic Health Record Review.
Who it may be relevant to
Registry conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Advancing Safe, Comprehensive, Digitally-Enabled Cancer Pain managemeNT (ASCENT)

Overview

This clinical trial tests a collaborative pain management intervention (ASCENT) for improving cancer pain in cancer survivors. Cancer pain is prevalent, under-treated, and remains a major cause of suffering, impairment, and disability for millions of Americans. Individual pain interventions and care models show promise for cancer pain in controlled settings. All cancer survivors stand to benefit from electronic health record innovations, as they can experience profound pain outcomes, including marked under- and over-prescribing of opioids. Digitally facilitated solutions are especially helpful and can be customized to address patient needs. The ASCENT intervention provides patients with an educational guide that describes techniques for addressing cancer pain, and uses community health workers and pain care managers to coach patients through a personalized pain management plan. This study may help researchers learn how pain management strategies can improve cancer pain and lower risk of opioid exposure and dependency in cancer survivors.

Detailed description

NOTE: Although Mayo Clinic in Arizona, Mayo Clinic in Florida, and Mayo Clinic in Rochester are the main study locations, this study is also recruiting (enrolling remotely) at the following Mayo Clinic Health System locations. The study is virtual/remote, so no travel is required.

Mayo Clinic Health Systems-Mankato Mankato, MN 56001, US

Mayo Clinic Health System in Albert Lea Albert Lea, MN 56007, US

Mayo Clinic Health System in Austin Austin, MN 55912, US

Mayo Clinic Health System-Eau Claire Clinic Eau Claire, WI 54701, US

Mayo Clinic Health System-Franciscan Healthcare La Crosse, WI 54601, US

PRIMARY OBJECTIVE:

I. To test a validated collaborative care model-based intervention aimed at improving pain control among cancer survivors by promoting multimodal pain care (MMPC) to reduce inappropriate opioid use and by addressing social determinants of health (SDOH) that impede a patient's access to appropriate care.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive enhanced usual care, which includes access to the educational and pain self-management materials developed for the ASCENT trial (the ASCENT guide).

ARM II: Patients receive the ASCENT guide and attend 3 video or phone calls over 30 minutes each with their community health worker (CHW) and/or pain care manager (PCM). During the first call, patients discuss barriers to receiving help for their pain with their CHW. During the second call, patients work with their PCM to develop an action plan for addressing their pain using the different techniques and interventions detailed in the ASCENT guide. During the third and final call, patients meet with both their CHW and PCM to discuss specialist recommendations for their pain management plan. After the final visit, patients will be contacted by the CHW or PCM every other week to monitor their progress and may also be contacted as-needed based on the their reported pain intensity, symptoms, or reported barriers.

Interventions

  • Other Best Practice
    Receive enhanced usual care
  • Other Educational Intervention
    Receive ASCENT guide
  • Other Questionnaire Administration
    Ancillary studies
  • Other Electronic Health Record Review
    Ancillary studies
  • Procedure Health Telemonitoring
    Attend video or phone calls with a CHW and/or PCM
  • Behavioral Cancer Pain Management
    Receive personalized pain management plan

Primary outcome measures

  • Change in Pain Score [Time frame: Baseline, 3 months, 6 months]
Secondary outcome measures (11)
  • Physical function [Time frame: Baseline, 3 months, 6 months]
  • Perceived Quality of Life [Time frame: Baseline, 3 months, 6 months]
  • Depression [Time frame: Baseline, 3 months, 6 months]
  • Anxiety [Time frame: Baseline, 3 months, 6 months]
  • Sleep [Time frame: Baseline, 3 months, 6 months]
  • Employment status [Time frame: Baseline, 3 months, 6 months]
  • Adherence to behavioral multimodal pain care plan components [Time frame: Baseline, 3 months, 6 months]
  • Use of study electronic-tools [Time frame: Baseline, 3 months, 6 months]
  • Social isolation [Time frame: Baseline, 3 months, 6 months]
  • Opioid consumption [Time frame: Up to 6 months]
  • Health care utilization [Time frame: Up to 6 months]

Eligibility criteria

Inclusion criteria

  • A qualifying liquid or solid cancer diagnosis with visits at a participating Mayo site in the past 15 years
  • Including malignant hematology
  • Lymphoma
  • Myeloma
  • Chronic leukemias
  • Age >= 18
  • Numeric Rating Scale (NRS) pain score of >= 5/10
  • Pain that developed or worsened following cancer diagnosis
  • Fit the description of either rural or Hispanic or both

Exclusion criteria

  • Patient Health Questionnaire - 8 (PHQ8) score of >= 13
  • Hospice enrollment
  • Skilled nursing facility, inpatient rehabilitation facility, or long-term care placement
  • Encounters with Palliative Care or the Pain Clinic in the past two months or upcoming two months
  • Any mention of hospice referral in medical oncology encounter notes (assess through textual search of the Mayo Data Explorer)
  • Affirmative response to, "Are you usually confined to a bed or chair more than a third of your waking hours because of your health?"
  • Currently homeless
  • Do not feel safe in their home
  • New or worsening chest pain, chest tightness, or chest pressure
  • Back pain that is associated with a new or worsening weakness, control of bowels/bladder, or difficulty walking
  • Lightheadedness, inability to keep down food or fluids, or vomiting blood or dark coffee-grounds-like material
  • New or worsening headaches that are associated with vision changes, nausea, balance issues, or problems with speech
  • Screens positive for use of non-cannabis drug use a a frequency of monthly or greater
  • Inability to engage with the intervention due to medical or psychological response

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

United States · 3 centers
  • Mayo Clinic in Arizona — Scottsdale
  • Mayo Clinic in Florida — Jacksonville
  • Mayo Clinic in Rochester — Rochester

Identifiers

NCT: NCT06198010 · ASCENT_MAIN · R33CA278594 · 23-010838

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗